Results of the Estimation of Biosimilarity of RinLiz<sup>®</sup> (LLC «GEROPHARM», Russia) and Humalog<sup>®</sup> (Lilly France, France) Using the Method of the Hyperinsulinemic Eulygemic Clamp on Healthy Voluntary

Results of the Estimation of Biosimilarity of RinLiz<sup>®</sup> (LLC «GEROPHARM», Russia) and Humalog<sup>®</sup> (Lilly France, France) Using the Method of the Hyperinsulinemic Eulygemic Clamp on Healthy Voluntary

Introduction. Insulin is the most effective hypoglycemic agent currently used in the clinical practice. Compared with recombinant human insulin, insulin lispro have a blood glucose profile that is much closer to physiological. The clinical trials program of insulin bioassays includes pharmacology st...

Full description

Bibliographic Details
Main Authors: A. Yu. Mayorov, I. A. Fedotov, R. V. Drai, O. I. Avdeeva, I. E. Makarenko
Format: Article
Language:Russian
Published: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2020-05-01
Series:Разработка и регистрация лекарственных средств
Subjects:
insulin lispro
biosimilar
clinical trials
pharmacokinetics
pharmacodynamics
comparability
clamp
Online Access:https://www.pharmjournal.ru/jour/article/view/776

Internet

https://www.pharmjournal.ru/jour/article/view/776

Similar Items